Companies · Other Health Care

SpeechVive Inc.

LAFAYETTE · Other Health Care

Diligence memoA one-page analyst read on SpeechVive Inc. — recommendation, valuation, rhythm, risks.
$3.3M
Total raised · real
3
Rounds
0.2×
Latest step-up
Top 44%
Sector rank · raised
Seed
Latest stage · inferred · Fri Aug 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time)

SpeechVive Inc. looks fair against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Fair
  • Modeled value is 0.85× the median modeled value of Seed Other Health Care companies in 2016–2018 (222 peers) — value vs value, same stage and era.
  • Within the normal band (85% of peer median) for its niche.
Dormant
  • Last raise 7.9 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

SpeechVive Inc. is one of 5376 Other Health Care companies tracked from LAFAYETTE. By capital raised it ranks mid-pack (ahead of 57% of sector peers), and mid-pack by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
6
Investors (latest)
2018-08-10
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$13M$25M$38M$50MPre-Seed · 2013-07-01 Raised $750K (real) Modeled valuation $23M (est)$750K$23MPre-Seed2013Pre-Seed · 2016-07-01 Raised $1.0M (real) Modeled valuation $31M (est)$1.0M$31MPre-Seed2016Seed · 2018-08-10 Raised $1.5M (real) Modeled valuation $38M (est)$1.5M$38MSeed2018Pre-Seed · 2018-08-10 Raised $280K (real) Modeled valuation $8.6M (est)$280K$8.6MPre-Seed2018+$1.0M+$1.5M+$280KCumulative $3.5M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Pre-Seed$750K · 2013
Pre-Seed extension$1.0M · 2016
Seed$1.5M · 2018
Bridge · Seed-stage$280K · 2018smaller follow-on

Stages are modeled from round size (public records carry no series label). Ladder is contiguous — every modeled rung has a record.

Modeled valuation trajectory
$37.5M
Base estimate est.
$1.3M
Conservative case
$294.4M
Upside case
$7.6M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Seeda $1.0M–$4.0M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Pre-Seed · modeled $23.1M · 2013-07-012013Pre-Seed · modeled $30.8M · 2016-07-01Seed · modeled $37.5M · 2018-08-10Pre-Seed · modeled $8.6M · 2018-08-102018
Model inputs · modeled:benchmark-stage-stepup-v1
20%
Dilution assumption
Implied ownership sold in the financing.
38%
Survival probability
17% low · 58% high
1.54×/yr
Annual markup
2.01×/yr upside case
6.0 yr
Elapsed time used
7.9 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
20 mo
Avg between rounds
$639K/yr
Capital velocity
13.0 yr
On record since
2013
First round
4
Rounds on file
How it compares to the market

Benchmarked against 5376 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 1.3× above median
This company$3.3M
Sector median$2.4M
Latest round — vs other Seed rounds in sector (real $, this stage) 0.2× of median
This company$280K
Sector median$1.7M
Modeled value — vs sector median (estimate, all stages) 1.7× above median
This company$37.5M
Sector median$22.1M

Raised more than 57% of sector peers (real $). Modeled value above 63% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Seed) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #125 of 222.

This companyCohort peer
$10.0M$100.0M$1.0B$1.0M$10.0MCapital raised (log)Eye Academy of America Ltd. · Seed Raised $4.0M · modeled $99.1M (est)Guest House Holdings, LLC · Seed Raised $4.0M · modeled $99.1M (est)Cb Therapeutics Inc. · Seed Raised $4.0M · modeled $99.1M (est)Ruddco Inc. · Seed Raised $4.0M · modeled $99.1M (est)Shift Sciences, LLC · Seed Raised $4.0M · modeled $98.6M (est)BHCP OK4 HH/H Investors, LLC · Seed Raised $4.0M · modeled $97.9M (est)ReNovo, Inc. · Seed Raised $4.0M · modeled $97.9M (est)CCRC of Lenexa, LLC · Seed Raised $3.9M · modeled $97.6M (est)Nocira, Llc · Seed Raised $3.9M · modeled $96.7M (est)PureFlowCath, LLC · Seed Raised $3.8M · modeled $94.6M (est)Prevent Biometrics, Inc. · Seed Raised $4.2M · modeled $94.2M (est)Medal, Inc. · Seed Raised $3.8M · modeled $93.6M (est)SpeechVive Inc. (this company) Raised $3.3M · modeled $37.5M (est)SpeechVive Inc.
CompanyStageRaised · realValue · estvs peer med.
Eye Academy of America Ltd.Seed$4.0M$99.1M2.23×
Guest House Holdings, LLCSeed$4.0M$99.1M2.23×
Cb Therapeutics Inc.Seed$4.0M$99.1M2.23×
Ruddco Inc.Seed$4.0M$99.1M2.23×
Shift Sciences, LLCSeed$4.0M$98.6M2.22×
BHCP OK4 HH/H Investors, LLCSeed$4.0M$97.9M2.21×
ReNovo, Inc.Seed$4.0M$97.9M2.21×
CCRC of Lenexa, LLCSeed$3.9M$97.6M2.20×
Nocira, LlcSeed$3.9M$96.7M2.18×
PureFlowCath, LLCSeed$3.8M$94.6M2.13×
Prevent Biometrics, Inc.Seed$4.2M$94.2M2.12×
Medal, Inc.Seed$3.8M$93.6M2.11×
SpeechVive Inc. this companySeed$3.3M$37.5M0.85×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Pre-Seed$750K2013-07-01$4.2M$23.1M85%
Pre-Seed$1.0M2016-07-01$5.6M$30.8M85%
Seed$1.5M2018-08-10$7.6M$37.5M90%
Pre-Seed$280K2018-08-10$1.6M$8.6M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Pre-Seed$750K2013-07-01
    • First recorded raise — entered as Pre-Seed.
  2. Pre-Seed$1.0M2016-07-01
    • Raised again after 36 mo — slower than the ~14 mo sector norm.
    • Round 1.3× larger than the prior — scaling up.
  3. Seed$1.5M2018-08-10
    • Raised again after 25 mo — slower than the ~14 mo sector norm.
    • Round 1.5× larger than the prior — scaling up.
    • 23 investors on this round.
  4. Pre-Seed$280K2018-08-10
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 5.4× smaller than the prior — bridge or down round.
    • 6 investors on this round.
Intelligence
2020 ~Q2
Modeled next raise · ~20mo cadence
$280K
Modeled next size est.range $280K$448K
0.2×
Last step-up
$639K/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Brian Kopp3 other2018-08
Bob Storey2013-07
Connell Sean2016-07
Jessica Huber2013-07
John Heretig2013-07
Keith Wells2016-07
Steve Mogensen2013-07
Registry & provenance

SpeechVive Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1593767
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Bespoke Innovations, Inc.Other Health CareSeed$3.2M$39.0Msame sector · same stage
beBetter Health, Inc.Other Health CareSeed$3.4M$39.9Msame sector · same stage
ViVre Medical, Inc.Other Health CareSeed$3.1M$39.0Msame sector · same stage
descendantsDNA, Inc.Other Health CareSeed$3.4M$40.8Msame sector · same stage
UVMC Investor, LLCOther Health CareSeed$3.4M$42.1Msame sector · same stage
CD Diagnostics, LLCOther Health CareSeed$3.1M$33.1Msame sector · same stage
Collabrx IncOther Health CareSeed$3.1M$38.8Msame sector · same stage
Ruthless Co.Other Health CareSeed$3.0M$34.6Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Speech South Associates LLCOther Health CarePre-Seed$9.2M86%
Diality IncOther Health CareSeries B$337.4M85%
LifeSpeak Inc.Other Health CareSeries B$2.3M84%
Origin Speech Therapy Inc.Other Health CareSeed$6.4M84%
CareView Communications IncOther Health CareSeries B$2.7M84%
NVOLVE, Inc.Other Health CarePre-Seed$5.0M84%
Talking Medicines LtdOther Health CareSeed$26.7M84%
TalkToMira, Inc.Other Health CareSeed$59.8M84%
Frequently asked
How much funding has SpeechVive Inc. raised?
SpeechVive Inc. has raised approximately $3.3M in disclosed capital across 3 recorded financing rounds, aggregated from public filings.
What is SpeechVive Inc.'s estimated valuation?
Provath's modeled valuation for SpeechVive Inc. is approximately $37.5M (modeled range $1.3M–$294.4M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is SpeechVive Inc. at?
SpeechVive Inc.'s latest modeled financing stage is Seed. Its most recent recorded round closed around Fri Aug 10.
What does SpeechVive Inc. do and where is it based?
SpeechVive Inc. operates in the Other Health Care sector, based in LAFAYETTE.
Explore related

See where SpeechVive Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at SpeechVive Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.